Shukui Wang
Impact in
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 2%
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 24
- RNA modifications and cancer 18
- Epigenetics and DNA Methylation 12
- RNA Research and Splicing 6
- Cancer-related gene regulation 5
-
- Cancer-related molecular mechanisms research 34
- MicroRNA in disease regulation 26
- Co-authors
- Yuqin Pan (79 shared papers)Bangshun He (58 shared papers)Xiangxiang Liu (40 shared papers)Huiling Sun (43 shared papers)Xiaoxiang Chen (28 shared papers)Kaixuan Zeng (23 shared papers)Mu Xu (24 shared papers)Bei Pan (26 shared papers)
- Journals
- Journal of Cancer (9 papers)Molecular Cancer (6 papers)Aging (6 papers)Cell Death and Disease (4 papers)OncoTargets and Therapy (4 papers)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Shukui Wang
143 papers receiving 6.2k citations
Shukui Wang's Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 2.7k
- Molecular Biology 3.4k
- Pharmacology 802
- Pharmacology 320
- Oncology 583
Countries citing papers authored by Shukui Wang
This map shows the geographic impact of Shukui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shukui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shukui Wang more than expected).
Fields of papers citing papers by Shukui Wang
This network shows the impact of papers produced by Shukui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shukui Wang. The network helps show where Shukui Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shukui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins Hit paper breakdown → | 2004 | 1188 |
| 2 | 2015 | 306 | |
| 3 | METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer Hit paper breakdown → | 2020 | 287 |
| 4 | 2011 | 253 | |
| 5 | 2018 | 239 | |
| 6 | 2018 | 239 | |
| 7 | 2019 | 206 | |
| 8 | 2019 | 202 | |
| 9 | 2018 | 174 | |
| 10 | 2019 | 162 | |
| 11 | 2008 | 158 | |
| 12 | 2018 | 112 | |
| 13 | 2018 | 106 | |
| 14 | 2018 | 96 | |
| 15 | 2018 | 92 | |
| 16 | 2019 | 83 | |
| 17 | 2019 | 77 | |
| 18 | 2019 | 76 | |
| 19 | 2021 | 75 | |
| 20 | 2018 | 74 |
About Shukui Wang
Shukui Wang is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 145 papers that have together received 6.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (34 papers), MicroRNA in disease regulation (26 papers), Circular RNAs in diseases (24 papers), RNA modifications and cancer (18 papers), Epigenetics and DNA Methylation (12 papers), Helicobacter pylori-related gastroenterology studies (11 papers), RNA Research and Splicing (6 papers) and Cancer-related gene regulation (5 papers). The work is most often cited by research in Cancer Research (2.7k citations), Molecular Biology (3.4k citations), Pharmacology (802 citations), Pharmacology (320 citations) and Oncology (583 citations). Shukui Wang has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Yuqin Pan, Bangshun He, Xiangxiang Liu, Huiling Sun, Xiaoxiang Chen, Kaixuan Zeng, Mu Xu, Bei Pan, Xueni Xu and Tao Xu. Their work appears in journals such as Journal of Cancer, Molecular Cancer, Aging, Cell Death and Disease and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.